TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.

Matthew P Goetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.